
Nordic Studies on Alcohol and Drugs, Journal Year: 2025, Volume and Issue: unknown
Published: March 25, 2025
Language: Английский
Nordic Studies on Alcohol and Drugs, Journal Year: 2025, Volume and Issue: unknown
Published: March 25, 2025
Language: Английский
Neuropsychopharmacology, Journal Year: 2018, Volume and Issue: 44(1), P. 166 - 183
Published: June 18, 2018
Language: Английский
Citations
393Psychiatry Research, Journal Year: 2020, Volume and Issue: 293, P. 113407 - 113407
Published: Aug. 18, 2020
Language: Английский
Citations
185JAMA Psychiatry, Journal Year: 2022, Volume and Issue: 79(7), P. 641 - 641
Published: June 1, 2022
Language: Английский
Citations
177JAMA Internal Medicine, Journal Year: 2020, Volume and Issue: 180(4), P. 574 - 574
Published: Feb. 10, 2020
Language: Английский
Citations
173Drug and Alcohol Dependence, Journal Year: 2019, Volume and Issue: 205, P. 107652 - 107652
Published: Oct. 22, 2019
Language: Английский
Citations
169World Psychiatry, Journal Year: 2023, Volume and Issue: 22(2), P. 203 - 229
Published: May 9, 2023
Substance use disorders (SUDs) are highly prevalent and exact a large toll on individuals’ health, well‐being, social functioning. Long‐lasting changes in brain networks involved reward, executive function, stress reactivity, mood, self‐awareness underlie the intense drive to consume substances inability control this urge person who suffers from addiction (moderate or severe SUD). Biological (including genetics developmental life stages) adverse childhood experiences) determinants of health recognized factors that contribute vulnerability for resilience against developing SUD. Consequently, prevention strategies target risk can improve outcomes and, when deployed adolescence, decrease these disorders. SUDs treatable, evidence clinically significant benefit exists medications (in opioid, nicotine alcohol disorders), behavioral therapies all SUDs), neuromodulation disorder). Treatment should be considered within context Chronic Care Model, with intensity intervention adjusted severity disorder concomitant treatment comorbid psychiatric physical conditions. Involvement care providers detection management SUDs, including referral cases specialized care, offers sustainable models further expanded telehealth. Despite advances our understanding individuals conditions continue stigmatized some countries, incarcerated, highlighting need dismantle policies perpetuate their criminalization instead develop ensure support access treatment.
Language: Английский
Citations
145Frontiers in Psychiatry, Journal Year: 2021, Volume and Issue: 12
Published: Oct. 25, 2021
The phenomenon of female preponderance in depression has been well-reported, which challenged by higher rates suicide and addictive behaviors males, a longer life-span females. We thus propose an alternative hypothesis “Gender differences self-reporting symptom depression,” suggesting mild-moderate tends to be reported more often females, severe tend males. Potential mechanisms that account for this difference may include three aspects: covariation between estrogen levels the incidence peak depression, gender coping style (e.g., comparative emotional inexpressiveness non-help-seeking males), phenotypes atypical symptoms male depression). Our newly presented implied overlooked under-diagnosis under-treatment For effective diagnoses timely treatment it is critical incorporate males into relevant diagnostic criteria, encourage express negative emotions, increase awareness suicidal behavior
Language: Английский
Citations
144JAMA Network Open, Journal Year: 2021, Volume and Issue: 4(2), P. e2036512 - e2036512
Published: Feb. 4, 2021
Substance use disorders are a major source of morbidity and mortality in the United States. National data comparing prevalence substance disorder diagnoses (SUDDs) among transgender cisgender individuals lacking To investigate SUDDs adults to identify within-group between-group differences by age, gender, geographic location. This cross-sectional study used OptumLabs Data Warehouse analyze deidentified claims from approximately 74 million aged 18 years or older enrolled commercial Medicare Advantage insurance plans 2017. A total 15 637 were identified based on previously developed algorithm using combination International Classification Diseases, Tenth Revision (ICD-10) transgender-related diagnosis procedure codes sex-discordant hormone prescriptions. cohort 46 911 was matched 3:1 ratio age SUDDs, ICD-10 codes, assessed overall compared between cohorts region (ie, Northeast, Midwest, South, West); groups (eg, 18-25, 26-30, 31-35 years), gender transfeminine [TF; assigned male sex at birth, along feminine spectrum], transmasculine [TM; female masculine male, female). In this (4955 [31.7%] TM) (23 247 [50.4%] men), most (8627 [55.2%]; 51 762 [55.2%]) 40 years, 6482 (41.5%) 19 446 lived South. Comparing groups, significant found nicotine (2594 [16.6%] vs 2551 [5.4%]; P < .001), alcohol (401 [2.6%] 438 [0.9%]; drug (678 [4.3%] 549 [1.2%]; .001) SUDDs. Among adults, cannabis prevalent SUDD (321 [2.1%]), followed opioid (205 [1.3%]) cocaine (81 [0.5%]), whereas equally (cannabis, 186 [0.4%]; opioid, 207 [0.4%]), (59 [0.1%]). study, significantly elevated relative their peers. These findings underscore need for culturally tailored clinical interventions treat populations.
Language: Английский
Citations
122Current Addiction Reports, Journal Year: 2021, Volume and Issue: 8(1), P. 89 - 99
Published: Feb. 16, 2021
Language: Английский
Citations
114Drug and Alcohol Dependence, Journal Year: 2020, Volume and Issue: 216, P. 108222 - 108222
Published: Aug. 3, 2020
Language: Английский
Citations
124